Form 4: SELLAS Life Sciences CEO Sells Shares to Cover Tax Obligations

SELLAS Life Sciences CEO, Angelos M. Stergiou, sold 28,289 shares of common stock to cover tax obligations related to vesting Restricted Stock Units.

Summary

• Angelos M. Stergiou, the President and CEO of SELLAS Life Sciences Group, Inc., sold 28,289 shares of common stock on December 4, 2024.
• The sale was executed at a price of $1.13 per share.
• This transaction was to cover tax withholding obligations related to the vesting of Restricted Stock Units (RSUs).
• Following the transaction, Mr. Stergiou directly owns 358,132 shares of common stock.

Sentiment

Score: 5

Explanation: The document reflects a routine transaction related to executive compensation and does not indicate any positive or negative sentiment.

Industry Context

This is a routine transaction for executives who receive stock-based compensation. It is common for executives to sell shares to cover tax obligations when RSUs vest.

Comparison to Industry Standards

• Executive stock sales to cover tax obligations are a common practice across the industry.
• Many companies use RSUs as part of their executive compensation packages, leading to similar transactions.
• The number of shares sold and the price are specific to the individual's holdings and the company's stock price at the time of vesting.

Stakeholder Impact

• The transaction has a minimal impact on shareholders as it is a routine sale to cover tax obligations.

Key Dates

Keywords

SELLAS Life Sciences, Angelos M. Stergiou, insider trading, Form 4, stock sale, tax obligations, restricted stock units, executive compensation